13F Data
13F filer · CIK 1663801

Bill & Melinda Gates Foundation

SEATTLE, WA · filing since Q4 2020 · last filing Nov 14, 2024
Reported value
$43.5M
+$3.3M vs prior
Positions
5
New / sold out
0 / 0
Added / reduced
0 / 1
Turnover
0.0%
buys $0 · sells $84.6K
Top-10 weight
100.0%

Biggest buys vs Q2 2024

No new or increased positions this quarter.

Biggest sells vs Q2 2024

ChangeSecurityShares changeChange %Est. trade value
ReducedCUREVAC N V-28,771-1.8%$-84.6K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2020: $437.8MQ1 2021: $611.1MQ2 2021: $650.8MQ3 2021: $341.6MQ4 2021: $329.6MQ1 2022: $186.0MQ2 2022: $130.1MQ3 2022: $126.5MQ4 2022: $129.8MQ1 2023: $113.2MQ2 2023: $125.6MQ3 2023: $83.9MQ4 2023: $89.9MQ1 2024: $84.1MQ2 2024: $40.2MQ3 2024: $43.5M
Q4 2020Q3 2024

Holdings · Q3 2024

#SecuritySharesValueWeight
1BIONTECH SESPONSORED ADS148,674$17.7M40.59%
2VIR BIOTECHNOLOGY INCCOM1,559,142$11.7M26.84%
3EXSCIENTIAADS1,590,909$7.8M17.85%
4CUREVAC N VCOM1,568,866$4.6M10.60%
5BUTTERFLY NETWORK INCCOM CL A1,011,003$1.8M4.11%